REGULATED INFORMATION
Publication relating to transparency notifications
Mont-Saint-Guibert (Belgium), October 25, 2024, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below.
Vestal Point Capital
On October 23, 2024, Nyxoah received a transparency notification from Vestal Point Capital following an acquisition or disposal of voting securities or voting rights. Based on the notification, Vestal Point Capital holds 3,000,688 voting rights, representing 8.03% of the total number of voting rights on October 9, 2024 (37,389,015).
The notification dated October 22, 2024 contains the following information:
A) Voting rights | Previous notification | After the transaction | |||
# of voting rights | # of voting rights | % of voting rights | |||
Holders of voting rights | Linked to securities | Not linked to the securities | Linked to securities | Not linked to the securities | |
Ryan Wilder | 0 | 0 | 0 | 0.00% | 0.00% |
Vestal Point Capital, LLC | 0 | 0 | 0 | 0.00% | 0.00% |
Vestal Point Capital, LP | 3,000,688 | 3,000,688 | 0 | 8.03% | 0.00% |
Subtotal | 3,000,688 | 3,000,688 | 8.03% | ||
TOTAL | 3,000,688 | 0 | 8.03% | 0.00% |
*
* *
Contact:
Nyxoah
Loic Moreau, CFO
IR@nyxoah.com
Attachment
Nearly 60% of patients with IgAN in the SPARTAN Study achieved complete remission when using…
Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN…
WARREN, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings…
LEIDEN, the Netherlands and CAMBRIDGE, Mass., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.…
TORONTO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ:…
CARLSBAD, Calif., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the…